Página 3 - Melhores Cancro do esófago médicos - TOP-109 médicos

O Dr. Ozden é especialista no tratamento do cancro do esófago, com vasta formação em oncologia médica.

• Licenciado pela Faculdade de Medicina Cerrahpaşa da Universidade de Istambul
• Conclusão da subespecialidade em oncologia médica na Universidade de Kocaeli
• Mais de uma década de experiência em medicina interna e oncologia
• Exerce no Hospital VM Medical Park Pendik

Specializations

Cancer Surgery

Pancreatic Surgery

Bile Duct Surgery

Bariatric Metabolic Surgery

Oncological Surgery

Breast Surgery

Gastric cancer

Colon cancer

Thyroid Cancer

Obesity Surgery

Diabetes Surgeries

O Professor Haciibrahimoglu é especialista em oncologia cirúrgica torácica, incluindo cancro do esófago, com perícia em cirurgia toracoscópica assistida por vídeo (VATS).

• Formação na Universidade Paris-Sud e na Faculdade de Medicina de Viena
• Mais de 20 anos de experiência em cirurgia torácica
• Membro da Sociedade Europeia de Cirurgiões Torácicos
• Publicação de 13 artigos internacionais sobre cirurgia torácica

Radioterapeuta especializado no tratamento do cancro do esófago no Assuta Medical Center.

• Focar-se em técnicas de radioterapia de precisão
• Trabalhar com equipas multidisciplinares para cuidados abrangentes
• Utilizar imagiologia avançada para tratamentos direcionados

O Dr. Klauzner é um dos melhores cirurgiões de Israel para o complexo procedimento de Whipple – uma grande operação para câncer de pâncreas e cancros relacionados, realizada no Sourasky Medical Center.

• Mais de 45 anos de experiência em cirurgia gastrointestinal
• Especializar-se em cirurgias de cólon, pâncreas e esôfago
• Exercer a liderança como Chefe de Cirurgia em seu hospital

Chefe do Departamento de Cirurgia Colorretal no Sourasky Medical Center e especialista de renome em cirurgia oncológica abdominal complexa.

• Mais de 20 anos de experiência cirúrgica
• Especializar-se em técnicas abertas e minimamente invasivas
• Realizar a cirurgia de Whipple para casos específicos
• Liderar o departamento de cirurgia colorretal em um centro médico de referência

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Subchefe do Departamento de Oncologia do Rambam Medical Center – especialista em casos complexos de cancro do esófago.

• Vasta experiência em oncologia com foco em cancro do esófago
• Trabalhar num centro médico de referência em Israel
• Realizar tanto o diagnóstico quanto o planeamento do tratamento

O Professor Jablonski-Perec formou-se no renomado Sloan-Kettering Cancer Center – trazendo especialização de classe mundial em cancro do esôfago para o Hadassah Medical Center.

• Chefiar o Instituto de Oncologia do Hadassah
• Ser professor no Departamento de Oncologia da Universidade Hebraica
• Ser membro de comunidades internacionais de pesquisa em cancro
• Ser beneficiário de uma bolsa da Faculdade de Medicina do Hadassah

Dr. Surender Dabas is a top cancer specialist in India with over 20 years of experience in treating head, neck, and thorax tumors. He is an expert in robotic surgery and has performed over 8,000 head-neck and thoracic cancer surgeries. He is dedicated to providing care to his patients in a relaxed environment.

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.

Professor Michele Reni is an experienced medical oncologist with over 30 years of practice based in Italy. He specializes in pancreatic adenocarcinoma, gastro-esophageal cancers, and central nervous system tumors. He has published over 180 papers on cancer treatment and is the coordinator of Italian Association of Medical Oncology (AIOM) guidelines for treatment and management of pancreatic cancer. He has also chaired numerous clinical trials on treating patients with metastatic pancreatic cancer.